News | ASTRO | October 26, 2022

CIVCO Radiotherapy, a global provider of radiotherapy solutions, has announced it is joining forces with Qfix, which provides patient positioning and immobilization devices.

CIVCO Radiotherapy has announced it is joining forces with Qfix, which provides patient positioning and immobilization devices.

Photo credit: CIVCO Radiotherapy


October 26, 2022 — CIVCO Radiotherapy, a global provider of radiotherapy solutions, has announced it is joining forces with Qfix, which provides patient positioning and immobilization devices. The announcement was made during the American Society for Radiation Oncology (ASTRO) 2022 Annual Meeting, held Oct. 23-26, in San Antonio, TX.      

“We are excited to combine two great companies,” said CIVCO Radiotherapy CEO Nat Geissel. “By joining together, our patients and providers will benefit from better customer service (sales coverage and customer care), new and improved products in radiotherapy and adjacent markets, and expanded R & D capabilities,” he added. The companies will be releasing additional details in the coming months,  as they work to integrate the two companies to effectively create and improve their customer-focused organization.

“CIVCO Radiotherapy looks forward to benefitting from Qfix’s robust internal manufacturing capabilities to accelerate innovation and deliver improved products, faster, while continuing to provide best-in-class customer care,” Geissel noted.

CIVCO Radiotherapy is celebrating 40 years of developing, manufacturing, and providing high-quality, innovative, patient-centric radiotherapy solutions in 2022. Solutions include advanced patient immobilization and positioning hardware and consumables, fiducial markers, couchtops and overlays, patient care products and advanced 6DOF robotic patient positioning. 
 

For more information: https://civcort.comhttps://qfix.com

Find more ASTRO22 content here 


Related Content

Feature | ASTRO | Christine Book

September 26, 2023 — Ahead of the 65th American Society for Radiation Oncology Annual Meeting, ASTRO 2023, ITN’s ...

Time September 26, 2023
arrow
News | Artificial Intelligence

September 25, 2023 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, today announced ...

Time September 25, 2023
arrow
Feature | Magnetic Resonance Imaging (MRI) | Robert L. Bard, MD, and Lennard M. Gettz, EdD

Since the advent of the magnetic resonance imaging (MRI) exam on human patients in the late 1970s, this innovation ...

Time September 25, 2023
arrow
News | Cardiac Imaging

September 21, 2023 — Declines in cardiovascular procedure volumes observed early in the COVID-19 pandemic greatly ...

Time September 21, 2023
arrow
News | X-Ray

September 21, 2023 — Scientists in Moscow have successfully engineered a prototype detector for X-ray and PET/CT ...

Time September 21, 2023
arrow
Feature | Radiation Oncology

The radiation oncology community lost a leader this past summer, with the passing of Jay Loeffler, MD, FACR, FASTRO. He ...

Time September 21, 2023
arrow
Feature | Proton Therapy | By Christine Book

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
arrow
News | Enterprise Imaging

September 20, 2023 — aycan, a recognized leader in medical imaging, announced today a new solution for reviewing DICOM ...

Time September 20, 2023
arrow
Feature | Radiation Dose Management | By Melinda Taschetta-Millane

Early-stage detection is key to the prevention of life-threatening diseases; however, limited access to data hinders the ...

Time September 20, 2023
arrow
Feature | Ultrasound Imaging | By Mustafa Hassan, PhD

Handheld ultrasound has not yet reached mainstream adoption, but the market is still forecast to reach over $500 million ...

Time September 20, 2023
arrow
Subscribe Now